Tasly Pharmaceutical Group Co. Ltd. (SHSE:600535) said it scraps plan to spin off BioPharm Unit for listing in Shanghai Star Market due to change in market environment.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.9 CNY | 0.00% | -3.37% | -12.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.46% | 3.06B | |
-15.69% | 4.49B | |
-0.12% | 3.04B | |
+0.47% | 2.61B | |
+36.06% | 1.81B | |
+0.84% | 1.66B | |
-10.60% | 1.63B | |
-12.03% | 1.55B | |
+36.40% | 1.41B | |
+38.10% | 1.34B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Tasly Pharmaceutical Group Scraps Plan to Spin Off BioPharm Unit for Listing